To content
.
Investor Portal
Menu
Home
Team
Fund 3
News
Fund 3
Sustainability-related
disclosures
Contact
Vesalius Biocapital
A European life sciences venture capital investor
.
About us
News
Vesalius News
11/16/2023
Memo Therapeutics: CEO Erik van den Berg
read more
11/02/2023
Memo Therapeutics: CHF 25 Million Financing
read more
10/04/2023
Rejuvenate Biomed: Positive results
read more
.
xxnoxx_zaehler